Contact
Please use this form to send email to PR contact of this press release:
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Multiple Myeloma
TO:
Please use this form to send email to PR contact of this press release:
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Multiple Myeloma
TO: